Research Partnership Between Shimadzu and the University of Texas at Arlington
The University of Texas at Arlington (UT) (Texas, USA) has announced its investment of $7.5 million into the creation of the Institute for Research Technologies at UT Arlington, adding to the philanthropic investment made by Shimadzu (Duisburg, Germany) earlier this year.
The University of Texas at Arlington (UT) (Texas, USA) has announced its investment of $7.5 million into the creation of the Institute for Research Technologies at UT Arlington, adding to the philanthropic investment made by Shimadzu (Duisburg, Germany) earlier this year. This brings the total investment in the formation of the institute to $25.2 million.
The new institute will incorporate three centres; the existing Shimadzu Centre for Advanced Analytical Chemistry, a new Centre for Imaging and a new Centre for Environmental, Forensic and Material Analysis. The Institute for Research Technologies will also have exclusive access within North America to equipment provided by Shimadzu.
"The integration of this wide-ranging technology throughout UT Arlington will provide our students with the critical and essential skills they need to enter the workforce," said Pamela Jansma, dean of the UT Arlington College of Science. "It also will help our University develop a robust influx of budding researchers at all degree levels."
"Shimadzu sees in UT Arlington an exciting energy, great vision and the potential to transform scientific research and education" commented Shuzo Maruyama, president of Shimadzu Scientific Instruments in Columbia, Maryland, USA. "We are delighted to have the opportunity to catalyze the potential of this great institution."
Shimadzu's partnership with UT was featured in the LCGC Europe Enews earlier this year. Please click here to read that feature.
For more information please visit:ref=http://www.uta.edu>www.uta.edu
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
